Demographic factors associated with timely treatment in women with breast cancer, Antioquia
PDF (Español (España))

Keywords

Breast Cancer
Women
Colombia

How to Cite

Gomez-Mercado, C. ., Segura-Cardona, Ángela ., Pájaro-Cantillo, D., Mesa-Largo, M. ., & Cadavid-Gil, M. . (2020). Demographic factors associated with timely treatment in women with breast cancer, Antioquia. Duazary, 17(3), 25–33. https://doi.org/10.21676/2389783X.3318

Abstract

Breast cancer is the leading cause of death in the world due to tumor diseases among women and the prognosis of a woman with this disease. This is an association between demographic factors and the timely treatment of women with breast cancer in Antioquia in the first half of 2017. A cross-sectional, retrospective study is carried out to identify the incidence of breast cancer and the association of Demographic Determinants There are no causes of patients with breast cancer and the opportunity in the treatment. There are 355 cases of breast cancer, for an incidence rate of 10.5 cases per 100,000 women. The associated demographic factors were: urban residence (RPA: 3.08 IC95%: 0.38-24.83), affiliation to the subsidized regime (RPA: 1.90 IC95%: 0.81-4.46), previous episodes of hospitalization (RPa: 1.90 IC95%: 0.81-4.46), late diagnosis ≥ 16 days (RPa: 0.46 IC95%: 0.18-1.19) and age (RPa: 0, 97 95% CI: 0.95-1.00). Timely treatment of cancer patients is associated with urban residence, affiliation to the subsidized regimen, previous episodes of hospitalization, late diagnosis and age.
https://doi.org/10.21676/2389783X.3318
PDF (Español (España))

References

1. Global Cancer Observatory [Internet]. [citado 28 de enero de 2019]. Disponible en: http://gco.iarc.fr/
2. Plan Decenal de Salud Pública [Internet]. [citado 28 de enero de 2019]. Disponible en: https://www.minsalud.gov.co/plandecenal/Paginas/home2013.aspx
3. Vergara-Dagobeth E, Suárez-Causado A, Gómez-Arias RD, Vergara-Dagobeth E, Suárez-Causado A, Gómez-Arias RD. Cancer Control Plan in Colombia 2012-2021. A Formal Analysis. Rev Gerenc Políticas Salud. diciembre de 2017;16(33):6-18. Disponible en: https://www.redalyc.org/html/545/54553416001/
4. Publicaciones | Instituto Nacional de Cancerologia [Internet]. [citado 28 de enero de 2019]. Disponible en: https://www.cancer.gov.co/publicaciones
5. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet Lond Engl. 3 de abril de 1999;353(9159):1119-26. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/10209974
6. Arndt V, Stürmer T, Stegmaier C, Ziegler H, Becker A, Brenner H. Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol Off J Am Soc Clin Oncol. 15 de abril de 2003;21(8):1440-6. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/12697864
7. Piñeros M, Sánchez R, Perry F, García OA, Ocampo R, Cendales R. Demoras en el diagnóstico y tratamiento de mujeres con cáncer de mama en Bogotá, Colombia. Salud Pública México. diciembre de 2011;53:478-85. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342011000600003
8. Abadia CE, Oviedo DG. Bureaucratic Itineraries in Colombia. A theoretical and methodological tool to assess managed-care health care systems. Soc Sci Med 1982. marzo de 2009;68(6):1153-60. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19178990
9. Hansen RP, Vedsted P, Sokolowski I, Søndergaard J, Olesen F. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 25 de octubre de 2011;11:284. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22027084
10. Pace LE, Mpunga T, Hategekimana V, Dusengimana J-MV, Habineza H, Bigirimana JB, et al. Delays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in Rwanda. The Oncologist. julio de 2015;20(7):780-8. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26032138
11. Sánchez G, Niño CG, Estupiñán C. Factores asociados con el tratamiento oportuno de mujeres con cáncer de mama apoyadas por una organización no gubernamental en Bogotá. Biomédica. 1 de diciembre de 2015;35(4):505-12. Disponible en: http://www.scielo.org.co/scielo.php?pid=S0120-41572015000400008&script=sci_abstract&tlng=es
12. Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Patient delay and stage of diagnosis among breast cancer patients in Germany -- a population based study. Br J Cancer. 8 de abril de 2002;86(7):1034-40. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/11953844
13. Burgess CC, Ramirez AJ, Richards MA, Love SB. Who and what influences delayed presentation in breast cancer? Br J Cancer. abril de 1998;77(8):1343-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150175/
14. Meechan G, Collins J, Petrie K. Delay in seeking medical care for self-detected breast symptoms in New Zealand women. N Z Med J. 22 de noviembre de 2002;115(1166):U257. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/12552275
15. Harirchi I, Ghaemmaghami F, Karbakhsh M, Moghimi R, Mazaherie H. Patient delay in women presenting with advanced breast cancer: an Iranian study. Public Health. octubre de 2005;119(10):885-91. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC166160/
16. Thongsuksai P, Chongsuvivatwong V, Sriplung H. Delay in breast cancer care: a study in Thai women. Med Care. enero de 2000;38(1):108-14. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/10630725
17. Piñeros M, Sánchez R, Cendales R, Perry F, Ocampo R. Patient delay among Colombian women with breast cancer. Salud Pública México. octubre de 2009;51:372-80. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19936550
18. Sánchez VG, Laza VC, Estupiñán GC, Estupiñán GL. Barriers to healthcare access: narratives of women with breast cancer in Colombia. Rev Fac Nac Salud Pública. diciembre de 2014;32(3):305-13. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-386X2014000300005
19. Rodríguez Ríos M, Uscanga Sánchez SR, Gutiérrez Vega P, Jiménez García GA. Factores asociados a la oportunidad en el diagnóstico de cáncer de mama. Rev Sanid Mil. 31 de octubre de 2017;57(5):291-8. Disponible en: http://www.imbiomed.com.mx/1/1/articulos.php?method=showDetail&id_articulo=18000&id_seccion=88&id_ejemplar=1879&id_revista=16
20. Gosain R, Pollock Y, Jain D. Age-related Disparity: Breast Cancer in the Elderly. Curr Oncol Rep. 2016;18(11):69. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27807821
21. de Charry LC, Carrasquilla G, Roca S. Equity regarding early breast cancer screening according to health insurance status in Colombia. Rev Salud Pública. octubre de 2008;10(4):571-82. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0124-00642008000400007
22. Sánchez G, Niño CG, Estupiñán AC. Determinantes del tratamiento oportuno en mujeres con cáncer de mama apoyadas por seis organizaciones no gubernamentales en Colombia. Rev Fac Nac Salud Pública. septiembre de 2016;34(3):297-305. Disponible en: https://aprendeenlinea.udea.edu.co/revistas/index.php/fnsp/article/view/20087/20782733
Commercial use of the original work or of possible derivative works is not allowed, the distribution of which must be done with a license equal to that which regulates the original work.
 
 
 
 

Downloads

Download data is not yet available.